Evidence map›Paper›PMID 25913618›Full record

ArticleScientific reports2015

Fluorescence-Activated Cell Sorting Analysis of Heterotypic Cell-in-Cell Structures.

Meifang He, Hongyan Huang, Manna Wang, Ang Chen, Xiangkai Ning, Kaitao Yu, Qihong Li, Wen Li, Li Ma, Zhaolie Chen and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Emperipolesis mediated by CD8Journal of cellular and molecular medicine · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 2 countries.

Meifang He1] Laboratory of General Surgery, The First Affiliated Hospital, Sun Yat-Sen University, 58 Zhongshan er Road, Guangzhou, Guangdong 510080, P. R. China [2] Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P. R. China [3] The Institute of Life Sciences, the Key Laboratory of Normal Aging &Geriatric, the State Key Laboratory of Kidney, the Chinese PLA General Hospital, Beijing 100853, P. R. China.
Hongyan Huang1] Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P. R. China [2] Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, 10 TIEYI Road, Beijing 100038, P. R. China.
Manna Wang1] Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P. R. China [2] Institute of Molecular Immunology, School of Biotechnology, Southern Medical University, Guangzhou 510515, P. R. China.
Ang ChenLaboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P. R. China.
Xiangkai Ning1] Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P. R. China [2] Institute of Molecular Immunology, School of Biotechnology, Southern Medical University, Guangzhou 510515, P. R. China.
Kaitao YuDepartment of Stomatology, Affiliated Hospital of Academy of Military Medical Science, 8 Dongda Street, Beijing 100071, P. R. China.
Qihong LiDepartment of Stomatology, Affiliated Hospital of Academy of Military Medical Science, 8 Dongda Street, Beijing 100071, P. R. China.
Wen LiLaboratory of General Surgery, The First Affiliated Hospital, Sun Yat-Sen University, 58 Zhongshan er Road, Guangzhou, Guangdong 510080, P. R. China.
Li MaInstitute of Molecular Immunology, School of Biotechnology, Southern Medical University, Guangzhou 510515, P. R. China.
Zhaolie ChenLaboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P. R. China.
Xiaoning WangThe Institute of Life Sciences, the Key Laboratory of Normal Aging &Geriatric, the State Key Laboratory of Kidney, the Chinese PLA General Hospital, Beijing 100853, P. R. China.
Qiang Sun1] Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P. R. China [2] National Key Laboratory of Medical Immunology and Institute of Immunology, Second Military Medical University, 800 Xiangyin Road, Shanghai 200433, P. R. China.
Southern Medical University · CNAcademy of Military Medical Sciences · CNCzech Academy of Sciences, Institute of Biotechnology · CZBeijing Shijitan Hospital · CNChinese PLA General Hospital · CNSecond Military Medical University · CNSun Yat-sen University · CNThe First Affiliated Hospital, Sun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell-in-cell structures (CICs), characterized by the presence of one or more viable cells inside another one, were recently found important player in development, immune homeostasis and tumorigenesis etc. Incompatible with ever-increasing interests on this unique phenomenon, reliable methods available for high throughput quantification and systemic investigation are lacking. Here, we report a flow cytometry-based method for rapid analysis and sorting of heterotypic CICs formed between lymphocytes and tumor cells. In this method, cells were labeled with fluorescent dyes for fluorescence-activated cell sorting (FACS) by flow cytometry, conditions for reducing cell doublets were optimized such that high purity (>95%) of CICs could be achieved. By taking advantage of this method, we analyzed CICs formation between different cell pairs, and found that factors from both internalized effector cells and engulfing target cells affect heterotypic CICs formation. Thus, flow cytometry-based FACS analysis would serve as a high throughput method to promote systemic researches on CICs.

Indexed as

Cell Line, TumorFlow CytometryFluorescenceFluorescent DyesHumansMCF-7 CellsFluorescent Dyes

Identifiers

PMID25913618
PMCPMC5386181
OpenAlexW1971266684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.